AIDA Survey

We are working on an AI tool to help detect gastric cancer early, but first, we need your views!

AIDA survey is anonymous, meaning no personal identifiers will be captured. All data will be pooled and analysed together.  

Please spread the word about the survey and help us develop an intelligent AI tool to detect cancer earlier!

The survey is available in multiple languages:

🇬🇧👉 https://digestivecancers.limesurvey.net/919165?lang=en

🇵🇹👉 https://digestivecancers.limesurvey.net/872374?lang=pt

🇳🇱👉 https://digestivecancers.limesurvey.net/415576?lang=nl

🇱🇻👉 https://digestivecancers.limesurvey.net/464112?lang=lv

🇱🇹👉https://digestivecancers.limesurvey.net/454558?lang=lt

🇫🇷👉 https://digestivecancers.limesurvey.net/165953?lang=fr

🇪🇸👉 https://digestivecancers.limesurvey.net/727798?lang=es

This survey is organised by Digestive Cancers Europe (DiCE) as part of the AIDA (Artificially Intelligent Diagnostic Assistant) project.

DiCE is an umbrella organisation representing nearly 40 national patient organisations across Europe. Our mission is to contribute to early diagnosis, decrease mortality from digestive cancers, and increase overall survival and quality of life. 

The AIDA project aims to develop and validate an artificial intelligence (AI) powered assistant that will support clinicians in gastric cancer prevention by diagnosing precancerous gastric inflammation and suggesting personalised therapeutics and monitoring.

Share

You might also be interested in

en

AIDA at ESMO GI Congress and DiCE’s Masterclass

AIDA proudly participated in the ESMO Gastrointestinal Cancers Congress and the Digestive Cancers Europe Masterclass, joining leading clinicians, researchers, and patient advocates to discuss the future of digestive cancer prevention.

en

AIDA Partner LU KPMI Represents Europe at HUG 2025 in Seoul

From 20–22 March, AIDA partner LU KPMI (University of Latvia) participated in the HUG 2025 Symposium in Seoul, South Korea, one of the leading international meetings focused on Helicobacter pylori and upper gastrointestinal diseases.